The Next Generation of Obesity Medicine: Cagrilintide for Weight Loss
The landscape of chronic weight management has evolved rapidly over the last few years. While single-target GLP-1 receptor agonists like semaglutide (Wegovy®) and dual-agonist treatments like tirzepatide (Mounjaro®) completely redefined what is clinically possible, medical science has advanced even further.…
